Dec 20, 2022
Recent advances in biologic medicines have revolutionized the treatment of many illnesses and conditions, from cancer to autoimmune diseases and many others. The FDA is also approving an increasing number of biologic treatments – including biosimilars –...
Nov 17, 2022
Press Contact: Sarah Shelsonsshelson@riesterpublicaffairs.com New framework for the evaluation of rare disease therapies prioritizes patient experiences, feedback, and needs WASHINGTON — Patients Rising, a non-profit organization that advocates on behalf of patients...
Mar 18, 2021
As part of the Patient Access and Affordability Project’s ongoing work to hold ICER accountable, we are pleased to announce a new report series, “The Last Word.” In this series, Dr. Paul Langley dissects and refutes the conclusions in ICER’s...
